Baird Financial Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,107
Closed -$328K 1802
2021
Q1
$328K Buy
4,107
+783
+24% +$61.1K ﹤0.01% 1487
2020
Q4
$262K Buy
+3,324
New +$195K ﹤0.01% 1413

Baird Financial Group's CMD Position: Q2 2021 in Review

Baird Financial Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,107 shares — an estimated $328K sold.

Baird Financial Group first reported a position in CMD in Q4 2020 and held it in 2 quarters. The position peaked at $328K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Baird Financial Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Baird Financial Group sold 4,107 Cantel Medical Corporation shares in Q2 2021, an estimated $328K.
  • Baird Financial Group first reported a position in Cantel Medical Corporation in Q4 2020 and held it in 2 quarters.
  • Baird Financial Group's Cantel Medical Corporation position peaked at $328K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Baird Financial Group's 13F filing for Q2 2021, filed 11 Aug 2021.